Eleven Biotherapeutics amends IPO

Eleven Biotherapeutics Inc., Cambridge, Mass. Business: Ophthalmic Date announced: 1/23/14 Type: IPO To be raised: Up to $64.5 million Shares: 4.3 million Price: $13-$15 Underwriters: Citigroup; Cowen...